The team behind the technology

Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.

Read More

Prenetics leadership team

Danny Yeung

Group CEO & Co-Founder Prenetics & CircleDNA

Avi Lasarow

CEO Prenetics EMEA & DNAfit, Hon. Consul South Africa to UK

Andrew Steele

Head of Product Prenetics EMEA & DNAfit

Rio Ferdinand

Subject Matter Expert Prenetics EMEA & DNAfit

Stan Tang

Head of PMO

Dr. Anna Mitchell

Head of Clinical Governance and Testing

Brian Stephenson

VP Market Development

Jotika Behari

Head of Risk & Compliance

Prenetics’ expert scientific consortium

Dr. Rachel Liebmann

Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists

Dr. Mark Atkin

Consultant Virologist, The Doctor’s Laboratory

Dr. Senthil Sundaram, MD

Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing

Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT

Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility

Scientific working group

Prof. Alan McNally, BSC, PhD

Director of Institute of Microbiology and Infection, University of Birmingham

Prof. Willem Van Schaik, MSc, PhD

Institute of Microbiology and infection, University of Birmingham

Prof. Michael M Yang, PhD

Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong

Dr. Richard H. Kaszynski, M.A, M.D,PhD

Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan

Company Address: Prenetics EMEA Ltd, Unit 2, Orpington Business Park, Faraday Way, Orpington, Kent BR5 3AA, United Kingdom

Company Registration Number: 08834823

© 2021 Project Screen | Privacy Policy | Terms of Service | Cookies Policy | All rights reserved